Related Experiment Video
Updated: May 25, 2026

A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells
Published on: March 28, 2021
5-Aryl-4-carboxamide-1,3-oxazoles: potent and selective GSK-3 inhibitors
Gabriella Gentile1, Giancarlo Merlo, Alfonso Pozzan
1Department of Medicinal Chemistry, Neuroscience Centre of Excellence of Drug Discovery, GlaxoSmithKline, Via A Fleming 4, 37135 Verona, Italy.
Abstract:
5-Aryl-4-carboxamide-1,3-oxazoles are a novel, potent and selective series of GSK-3 inhibitors. The optimization of the series to yield compounds with cell activity and brain permeability is described.
Related Concept Videos
Dipeptidyl Peptidase 4 Inhibitors
Inhibition of CDK Activity
Inhibition of Cdk Activity
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
